Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Omeprazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP4A known ✓ | P20648 | 7/20 | 0.50 |
| ▸ | ATP4B known ✓ | P51164 | 7/20 | 0.50 |
| ▸ | BRS3 | P32247 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | ATP1A1 | P05023 | 4/20 | 0.50 |
| ▸ | ATP1B1 | P05026 | 4/20 | 0.50 |
| ▸ | ATP1A3 | P13637 | 4/20 | 0.50 |
| ▸ | ATP1B2 | P14415 | 4/20 | 0.50 |
| ▸ | ATP1A2 | P50993 | 4/20 | 0.50 |
| ▸ | ATP1B3 | P54709 | 4/20 | 0.50 |
| ▸ | FXYD2 | P54710 | 4/20 | 0.50 |
| ▸ | ATP1A4 | Q13733 | 4/20 | 0.50 |
| ▸ | WDR5 | P61964 | 3/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | DDAH1 | O94760 | 2/20 | 0.50 |
| ▸ | ENGASE | Q8NFI3 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Omeprazole SCHEMBL28256110 | 1.00 | BRS3 (0.52) | BRS3ATP4AATP4BKMT2AATP1A1 | |
| Omeprazole SCHEMBL30179968 | 1.00 | BRS3 (0.52) | BRS3ATP4AATP4BKMT2AATP1A1 | |
| Omeprazole SCHEMBL1560978 | 1.00 | BRS3 (0.52) | BRS3ATP4AATP4BKMT2AATP1A1 | |
| Omeprazole SCHEMBL29538900 | 1.00 | BRS3 (0.52) | BRS3ATP4AATP4BKMT2AATP1A1 | |
| Omeprazole SCHEMBL1560726 | 1.00 | BRS3 (0.52) | BRS3ATP4AATP4BKMT2AATP1A1 | |
| Esomeprazole SCHEMBL21628 | 1.00 | BRS3 (0.52) | BRS3ATP4AATP4BKMT2AATP1A1 | |
| Omeprazole SCHEMBL82985 | 1.00 | BRS3 (0.52) | BRS3ATP4AATP4BKMT2AATP1A1 | |
| Esomeprazole SCHEMBL29350786 | 1.00 | BRS3 (0.52) | BRS3ATP4AATP4BKMT2AATP1A1 | |
| Esomeprazole SCHEMBL29673044 | 1.00 | BRS3 (0.52) | BRS3ATP4AATP4BKMT2AATP1A1 | |
| Omeprazole SCHEMBL23780638 | 0.99 | BRS3 (0.51) | BRS3ATP4AATP4BKMT2AATP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 59299 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116794308-B | Application of beta-1, 4-galactosyltransferase 1 and inhibitor thereof in preparation of medicines for treating acute and chronic liver diseases | CHINA PHARMACEUTICAL UNIVERSITY (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122075405-A | Compound omeprazole dry suspension and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026107208-A1 | COMPOSITIONS AND METHODS FOR TREATING MICROBIAL INFECTIONS | THE METHODIST HOSPITAL (US) | 2026-05-21 | — | — | WO | claimed |
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| WO-2026097604-A1 | COMPOSITION AND DRUG-DEVICE COMBINATION PRODUCT FOR LOCAL TUMOR ADMINISTRATION, AND USE | 诺曼德美国有限责任公司 | 2026-05-15 | — | — | WO | claimed |
| WO-2026101534-A1 | MYOSTATIN AND ACTIVIN A IMMUNOGENS AND METHODS OF USE | VAXXINITY, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| US-12622900-B2 | Methods and compositions for treating gastric ulcers | Luoda Pharma Limited (IE) | 2026-05-12 | — | — | US | claimed |
| EP-4735895-A1 | HELICOBACTER CAGA PEPTIDES AND THEIR USE IN DIAGNOSIS | Biotome Pty Ltd (AU) | 2026-05-06 | — | — | EP | claimed |
| EP-4734952-A1 | ORAL TABLET WITH IMPROVED UNIFORMITY OF CONTENT OF ACTIVES | Fertin Pharma A/S (DK) | 2026-05-06 | — | — | EP | claimed |
| US-20260117393-A1 | ETCHING AGENT COMPOSITION AND ETCHING METHOD USING THE SAME | KCTECH CO., LTD. (KR) | 2026-04-30 | — | — | US | claimed |
| EP-0041574-A1 | THERMAL ENERGY CONVERSION SYSTEM AND METHOD UTILIZING UNENCASED EXPANDITES | SORENSEN, Jens Ole (US) | 1981-12-16 | — | — | EP | claimed |
| WO-1981002606-A1 | ROTARY PISTON ENGINE | KEPLINGER K | 1981-09-17 | — | — | WO | claimed |
| WO-1981001724-A1 | THERMAL ENERGY CONVERSION SYSTEM AND METHOD UTILIZING UNENASED EXPANDITES | SORENSEN J | 1981-06-25 | — | — | WO | claimed |
| WO-1981001677-A1 | MAGNETIC HOLDING APPARATUS,AND METHODS OF CONSTRUCTING AND UTILIZING SAME | COX L (US) | 1981-06-25 | — | — | WO | claimed |
| EP-0005129-B1 | SUBSTITUTED PYRIDYLSULFINYLBENZIMIDAZOLES HAVING GASTRIC ACID SECRETION PROPERTIES, PHARMACEUTICAL PREPARATIONS CONTAINING SAME, AND INTERMEDIATES FOR THEIR PREPARATION | Aktiebolaget Hässle (SE) | 1981-04-29 | — | — | EP | claimed |
| WO-1981000032-A1 | ELECTROCHEMICAL CELL AND GAS DIFFUSION ELECTRODE FOR THE SAME | SVENSKA UTVECKLINGS AB (SE) | 1981-01-08 | — | — | WO | claimed |
| WO-1980002068-A1 | DOUBLE ACTION,PNEUMATIC BOLT AND SEAR BUFFER FOR AUTOMATIC CANNON | ARES INC (US) | 1980-10-02 | — | — | WO | claimed |
| EP-0009028-A1 | IMPROVEMENTS IN OR RELATING TO CASTING METAL INGOTS | VALLAK, Enn (CH) | 1980-03-19 | — | — | EP | claimed |
| WO-1979000596-A1 | IMPROVEMENTS IN OR RELATING TO CASTING METAL INGOTS | VALLAK E | 1979-08-23 | — | — | WO | claimed |
| US-3978100-A | Allenic esters, process for preparation thereof and process for rearrangement thereof | KURARAY CO., LTD. (JA) | 1976-08-31 | — | — | US | claimed |